Company · CIK 0001517681 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Propanc Health Group Corp · PPCB
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 4, 2015 JForm 4 → | Sep 27, 2016, 4:39 pm EDT | James Andrew NathanielszCEO, CFO, Secretary, Treasurer, Director | 33,259,350 | — | — | 42,711,111 | — | plan? late |
| Feb 4, 2015 JForm 4 → | Sep 27, 2016, 4:34 pm EDT | Julian Norman KenyonDirector | 17,654,470 | — | — | 28,466,534 | — | plan? late |
| Sep 4, 2012 SForm 4 → | Jan 13, 2015, 9:04 am EST | James Andrew NathanielszChief Executive Officer, Director, 10% Owner | 330,500 | $0.1818 | $60,083 | 9,701,761 | −3.29% | plan? late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 14, 2016 AForm 4 → | Sep 27, 4:39 pm EDT | James Andrew NathanielszCEO, CFO, Secretary, Treasurer, Director | 71,500,000 | — | — | 71,500,000 | — | late |
| Apr 14, 2016 AForm 4 → | Sep 27, 4:34 pm EDT | Julian Norman KenyonDirector | 71,500,000 | — | — | 71,500,000 | — | late |
| Nov 9, 2014 AForm 4 → | Jan 13, 2015, 9:04 am EST | James Andrew NathanielszChief Executive Officer, Director, 10% Owner | 500,000 | — | — | 500,000 | — | late |